bpc 157 clinical trial recruiting BPC-157 + TB-500 Blend Bpc 157 bone healing: 2025's
Description
SLU-PP-332 5mg SL-UP-332 is a synthetic research compound known as an "exercise mimetic" that shows promise in animal studies for treating metabolic diseases, enhancing endurance, and potentially aiding in the prevention of severe COVID-19
They are typically less than 2mm wide at the surface but extend vertically downward through the dermis and in severe cases into the subcutaneous tissue beneath
BPC-157 ability to protect against this specific toxic insult suggests potential relevance for dopaminergic neuroprotection
Two separate human clinical trials (ulcerative colitis and multiple sclerosis) proceeded without significant adverse event reporting
